Clostridium Difficile Diagnostics and Treatment Market - by Product Type (By Drug (Metronidazole, Vancomycin, Fidaxomicin, and Bezlotoxumab), By Diagnostic Test (Enzyme Immunoassays, Real-Time Polymerase Chain Reaction (RT-PCR), Nucleic Amplification Tests (NAAT), and Others)), By Distribution Channel (Hospitals & Clinics, Diagnostic Laboratories, and Pharmacies), and Region - Global Industry Insights, and Forecast till 2025
Select a license type that suits your business needs
Single User License
US$ 4,500
US$ 3,500
Three thousand five hundred dollars
Report accessible by 1 user only
Free 20% or 35 hours of customisation
Free post-sale service assistance
Direct access to lead analyst
Frequently purchased
Multi User License
US$ 7,000
US$ 5,500
Five thousand five hundred dollars
Report accessible by 7 users
Free 30% or 70 hours of customisation
Free post-sale service assistance
Direct access to lead analysts
25% discount on your next purchase
Dedicated account manager
Personalized market brief by the lead author, if needed
Printable version of the report
Corporate User License
US$ 10,000
US$ 7,500
Seven thousand five hundred dollars
Report accessible to unlimited users
Free 35% or 85 hours of customisation
Free post-sale service assistance
Direct access to lead analysts
30% discount on your next purchase
Dedicated account manager
Personalized market brief by the lead author, if needed